{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:56:59Z","timestamp":1771991819290,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2012,6,8]]},"published-print":{"date-parts":[[2012]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A variety of techniques are available for antimicrobial susceptibility testing of<jats:italic>Neisseria gonorrhoeae<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to find a cost-effective, reliable and easily applicable microbiological method to detect antimicrobial susceptibilities of<jats:italic>N. gonorrhoeae<\/jats:italic>in resource-poor countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Male and female STD clinic of Regional STD Teaching, Training and Research Centre, New Delhi, India.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p><jats:italic>N. gonorrhoeae<\/jats:italic>isolates from all male and female patients presenting with acute gonococcal urethritis and cervical discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>A total of 295 consecutive<jats:italic>N. gonorrhoeae<\/jats:italic>isolates during 2005\u20132010 was used to compare the Clinical and Laboratory Standards Institute (CLSI) and CDS disc diffusion technique with Etest by performing antimicrobial susceptibility testing in parallel for penicillin, tetracycline, ceftriaxone, ciprofloxacin and spectinomycin. WHO reference strains were used as controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CDS disc diffusion zones of inhibition showed that complete percentage agreement for penicillin, ciprofloxacin and tetracycline was high with their analogous Etest minimal inhibitory concentrations in comparison to CLSI disc diffusion technique, that is, 91.5%, 92.9% and 99.3% versus 87.5%, 88.5% and 74.9%, respectively. CDS results had less number of major and minor category discrepancies in comparison to CLSI and CDS method showed excellent correlation coefficient (r=1) with Etest for all five antimicrobial agents tested in comparison to CLSI (r=0.92). It was very poor (r=0.61) by CLSI method for tetracycline. The correlation coefficients between the two methods and the Etest were identical if tetracycline was removed from the CLSI analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The CDS technique is an attractive alternative for<jats:italic>N. gonorrhoeae<\/jats:italic>susceptibility testing and is recommended for monitoring the antimicrobial susceptibility in less developed and resource-poor settings to facilitate enhanced antimicrobial resistance surveillance when the WHO Gonococcal Antimicrobial Surveillance Programme is undergoing expansion to meet the ongoing challenges of surveillance and control of gonococcal antimicrobial resistance.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2012-000969","type":"journal-article","created":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T21:48:21Z","timestamp":1341438501000},"page":"e000969","source":"Crossref","is-referenced-by-count":22,"title":["Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of<i>Neisseria gonorrhoeae<\/i>: a 6-year study"],"prefix":"10.1136","volume":"2","author":[{"given":"Vikram","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kakran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,7,2]]},"reference":[{"key":"2024051503352850000_2.4.e000969.1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/45.4_ts.493"},{"key":"2024051503352850000_2.4.e000969.2","unstructured":"National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test. Tentative standard, M2-T4. Vol. 8. Villanova, PA: National Committee for Clinical Laboratory Standards, 1988."},{"key":"2024051503352850000_2.4.e000969.3","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Tentative standard, M7-T2. Vol. 8. Villanova, PA: National Committee for Clinical Laboratory Standards, 1988."},{"issue":"Suppl 217","key":"2024051503352850000_2.4.e000969.4","first-page":"1","article-title":"Antibiotic sensitivity testing. Report of an international collaborative study","volume":"217","author":"Ericsson","year":"1971","journal-title":"Acta Pathol Microbiol Scand B Microbiol Immunol"},{"key":"2024051503352850000_2.4.e000969.5","doi-asserted-by":"publisher","DOI":"10.3109\/00313027509082602"},{"key":"2024051503352850000_2.4.e000969.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm238"},{"key":"2024051503352850000_2.4.e000969.7","doi-asserted-by":"crossref","first-page":"pii: 19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051503352850000_2.4.e000969.8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"2024051503352850000_2.4.e000969.9","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(92)90090-G"},{"key":"2024051503352850000_2.4.e000969.10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/jcm.32.6.1586-1588.1994","article-title":"Comparison of E test with agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"32","author":"Dyck","year":"1994","journal-title":"J Clin Microbiol"},{"key":"2024051503352850000_2.4.e000969.11","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/jcm.31.11.3053-3055.1993","article-title":"Evaluation of Etest for testing antimicrobial susceptibilities of Neisseria gonorrhoeae isolates with different growth media","volume":"31","author":"Yeung","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2024051503352850000_2.4.e000969.12","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268809990148"},{"key":"2024051503352850000_2.4.e000969.13","first-page":"48","article-title":"Comparison of disc diffusion results with minimum inhibitory concentration (MIC) values for antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"122","author":"Bala","year":"2005","journal-title":"Indian J Med Res"},{"key":"2024051503352850000_2.4.e000969.14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0463.2011.02729.x","article-title":"Cefpodoxime 10 \u03bcg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes","volume":"119","author":"Limnios","year":"2011","journal-title":"APMIS"},{"key":"2024051503352850000_2.4.e000969.15","unstructured":"Laboratory diagnosis of gonorrhoea. WHO Regional Publication, South East Asia Series No 33. Geneva: World health Organisation, 1999. http:\/\/w3.whosea.org\/book33\/ (accessed 22 Dec 2011)."},{"key":"2024051503352850000_2.4.e000969.16","unstructured":"Bell SM Pham JN Fisher GT . Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories. 5th edn. 2009:P42\u201358. http:\/\/web.med.unsw.edu.au\/cdstest (accessed 22 Dec 2011)."},{"key":"2024051503352850000_2.4.e000969.17","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Seventeenth Informational Supplement. CLSI Document M100-S17. Wayne, USA: Clinical and Laboratory Standards Institute, 2007."},{"key":"2024051503352850000_2.4.e000969.18","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"2024051503352850000_2.4.e000969.19","unstructured":"U.S. Food and Drug Administration. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. U.S. Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health. 2007. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm080187.htm (accessed 28 Dec 2011)."},{"key":"2024051503352850000_2.4.e000969.20","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1128\/jcm.34.12.3214-3217.1996","article-title":"Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration","volume":"34","author":"Biedenbach","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2024051503352850000_2.4.e000969.21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007435-200002000-00010","article-title":"Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics: report of resistant isolates and surveillance in Zhanjiang, China: 1998 to 1999","volume":"27","author":"Guoming","year":"2000","journal-title":"Sex Transm Dis"},{"key":"2024051503352850000_2.4.e000969.22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0732-8893(91)90065-N","article-title":"Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines","volume":"14","author":"Jones","year":"1990","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2012-000969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T14:06:37Z","timestamp":1715781997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2012-000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,7,2]]},"published-print":{"date-parts":[[2012]]}},"alternative-id":["10.1136\/bmjopen-2012-000969"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2012-000969","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}